Equity: Global Genomic Advancements ETFs (segment)
This page lists all 5 US-listed ETFs in the Equity: Global Genomic Advancements segment with combined assets of $1.61B. Returns are aggregated using AUM-weighting where applicable.
Category Returns (AUM-Weighted)
| Period | AUM-Weighted | Simple Avg |
|---|---|---|
| 1 Day | -0.78% | -1.06% |
| 1 Week | -4.08% | -1.76% |
| 1 Month | 7.32% | 2.41% |
| 3 Months | 15.30% | 6.21% |
| 6 Months | 6.18% | 4.76% |
| YTD | 13.49% | 6.65% |
| 1 Year | 41.89% | 32.01% |
| 3 Years | 0.38% | 9.81% |
| 5 Years | -56.89% | -41.07% |
| 10 Years | — | — |
Top Equity: Global Genomic Advancements ETFs by AUM
| Symbol | Fund Name | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | $1.37B | 0.01% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | $160.61M | 0.00% |
| GNOM | Global X Genomics & Biotechnology ETF | $57.86M | 0.01% |
| HELX | Franklin Genomic Advancements ETF | $22.53M | 0.01% |
| SYNB | Putnam BioRevolution ETF | — | 0.01% |